27T51 + Bevacizumab + Cemiplimab
|
27T51
Bevacizumab
Cemiplimab
|
0 |
1 |
81C6 + Bevacizumab
|
81C6
Bevacizumab
|
0 |
1 |
Abaloparatide + Bevacizumab
|
Abaloparatide
Bevacizumab
|
0 |
1 |
ABBV-400 + Bevacizumab
|
ABBV-400
Bevacizumab
|
0 |
1 |
ABBV-400 + Bevacizumab + Fluorouracil + Leucovorin
|
ABBV-400
Bevacizumab
Fluorouracil
Leucovorin
|
0 |
1 |
Abemaciclib + Bevacizumab
|
Abemaciclib
Bevacizumab
|
0 |
1 |
ABT-751 + Bevacizumab + Capecitabine + Irinotecan
|
ABT-751
Bevacizumab
Capecitabine
Irinotecan
|
0 |
0 |
Ad-CEA vaccine + Avelumab + Bevacizumab + Capecitabine
|
Ad-CEA vaccine
Avelumab
Bevacizumab
Capecitabine
|
0 |
1 |
Ad-CEA vaccine + Avelumab + Bevacizumab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin
|
Ad-CEA vaccine
Avelumab
Bevacizumab
Capecitabine
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
1 |
Ad-CEA vaccine + Avelumab + Bevacizumab + Leucovorin + Oxaliplatin
|
Ad-CEA vaccine
Avelumab
Bevacizumab
Leucovorin
Oxaliplatin
|
0 |
0 |
ADI-PEG 20 + Atezolizumab + Bevacizumab
|
ADI-PEG 20
Atezolizumab
Bevacizumab
|
0 |
1 |
Afatinib + Bevacizumab
|
Afatinib
Bevacizumab
|
0 |
0 |
Aldesleukin + Bevacizumab
|
Aldesleukin
Bevacizumab
|
0 |
1 |
Aldoxorubicin + Avelumab + Bevacizumab + Capecitabine + Cyclophosphamide + ETBX-011 + ETBX-021 + ETBX-051 + ETBX-061 + Fluorouracil + Gemcitabine + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Nogapendekin alfa inbakicept + Oxaliplatin
|
Aldoxorubicin
Avelumab
Bevacizumab
Capecitabine
Cyclophosphamide
ETBX-011
ETBX-021
ETBX-051
ETBX-061
Fluorouracil
GI-4000
GI-6207
GI-6301
Gemcitabine
Leucovorin
Nab-paclitaxel
Nogapendekin alfa inbakicept
Oxaliplatin
haNK cells
|
0 |
2 |
Alpha 2 Interferon + Bevacizumab
|
Alpha 2 Interferon
Bevacizumab
|
1 |
0 |
Altiratinib + Bevacizumab
|
Altiratinib
Bevacizumab
|
0 |
0 |
Amivantamab-vmjw + Bevacizumab + Lazertinib
|
Amivantamab-vmjw
Bevacizumab
Lazertinib
|
0 |
1 |
Anakinra + Bevacizumab + Fluorouracil + Oxaliplatin + Trametinib
|
Anakinra
Bevacizumab
Fluorouracil
Oxaliplatin
Trametinib
|
0 |
0 |
Andecaliximab + Bevacizumab
|
Andecaliximab
Bevacizumab
|
0 |
1 |
Anetumab ravtansine + Bevacizumab
|
Anetumab ravtansine
Bevacizumab
|
0 |
1 |
Arfolitixorin + Bevacizumab + Fluorouracil + Oxaliplatin
|
Arfolitixorin
Bevacizumab
Fluorouracil
Oxaliplatin
|
0 |
1 |
Aspirin + Bevacizumab + Capecitabine + Cyclophosphamide + Fluorouracil + Irinotecan + Leucovorin + Regorafenib
|
Aspirin
Bevacizumab
Capecitabine
Cyclophosphamide
Fluorouracil
Irinotecan
Leucovorin
Regorafenib
|
0 |
1 |
Aspirin + Bevacizumab + Capecitabine + Cyclophosphamide + Fluorouracil + Leucovorin + Oxaliplatin + Regorafenib
|
Aspirin
Bevacizumab
Capecitabine
Cyclophosphamide
Fluorouracil
Leucovorin
Oxaliplatin
Regorafenib
|
0 |
1 |
Atezolizumab + Bevacizumab
|
Atezolizumab
Bevacizumab
|
0 |
52 |
Atezolizumab + Bevacizumab + C188-9
|
Atezolizumab
Bevacizumab
C188-9
|
0 |
1 |
Atezolizumab + Bevacizumab + Capecitabine
|
Atezolizumab
Bevacizumab
Capecitabine
|
0 |
4 |
Atezolizumab + Bevacizumab + Capecitabine + Oxaliplatin
|
Atezolizumab
Bevacizumab
Capecitabine
Oxaliplatin
|
0 |
1 |
Atezolizumab + Bevacizumab + Carboplatin
|
Atezolizumab
Bevacizumab
Carboplatin
|
0 |
1 |
Atezolizumab + Bevacizumab + Carboplatin + Etoposide
|
Atezolizumab
Bevacizumab
Carboplatin
Etoposide
|
0 |
1 |
Atezolizumab + Bevacizumab + Carboplatin + Gemcitabine
|
Atezolizumab
Bevacizumab
Carboplatin
Gemcitabine
|
0 |
1 |
Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel
|
Atezolizumab
Bevacizumab
Carboplatin
Paclitaxel
|
0 |
4 |
Atezolizumab + Bevacizumab + Carboplatin + Pegylated liposomal doxorubicin
|
Atezolizumab
Bevacizumab
Carboplatin
Pegylated liposomal doxorubicin
|
0 |
0 |
Atezolizumab + Bevacizumab + Carboplatin + Pemetrexed Disodium
|
Atezolizumab
Bevacizumab
Carboplatin
Pemetrexed Disodium
|
0 |
6 |
Atezolizumab + Bevacizumab + Cisplatin
|
Atezolizumab
Bevacizumab
Cisplatin
|
0 |
1 |
Atezolizumab + Bevacizumab + Cisplatin + Gemcitabine
|
Atezolizumab
Bevacizumab
Cisplatin
Gemcitabine
|
0 |
2 |
Atezolizumab + Bevacizumab + Cisplatin + Paclitaxel
|
Atezolizumab
Bevacizumab
Cisplatin
Paclitaxel
|
0 |
1 |
Atezolizumab + Bevacizumab + Cisplatin + Pemetrexed Disodium
|
Atezolizumab
Bevacizumab
Cisplatin
Pemetrexed Disodium
|
0 |
1 |
Atezolizumab + Bevacizumab + Cobimetinib
|
Atezolizumab
Bevacizumab
Cobimetinib
|
0 |
3 |
Atezolizumab + Bevacizumab + Cyclophosphamide + Sorafenib
|
Atezolizumab
Bevacizumab
Cyclophosphamide
Sorafenib
|
0 |
1 |
Atezolizumab + Bevacizumab + DS-3201b
|
Atezolizumab
Bevacizumab
DS-3201b
|
0 |
1 |
Atezolizumab + Bevacizumab + Eganelisib
|
Atezolizumab
Bevacizumab
Eganelisib
|
0 |
1 |
Atezolizumab + Bevacizumab + Entinostat
|
Atezolizumab
Bevacizumab
Entinostat
|
0 |
1 |
Atezolizumab + Bevacizumab + Erlotinib
|
Atezolizumab
Bevacizumab
Erlotinib
|
0 |
1 |
Atezolizumab + Bevacizumab + Exemestane
|
Atezolizumab
Bevacizumab
Exemestane
|
0 |
1 |
Atezolizumab + Bevacizumab + EXL01
|
Atezolizumab
Bevacizumab
EXL01
|
0 |
1 |
Atezolizumab + Bevacizumab + Fecal microbiota
|
Atezolizumab
Bevacizumab
Fecal microbiota
|
0 |
1 |
Atezolizumab + Bevacizumab + Fecal microbiota + Vancomycin
|
Atezolizumab
Bevacizumab
Fecal microbiota
Vancomycin
|
0 |
1 |
Atezolizumab + Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin
|
Atezolizumab
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
3 |
Atezolizumab + Bevacizumab + Fulvestrant
|
Atezolizumab
Bevacizumab
Fulvestrant
|
0 |
1 |
Atezolizumab + Bevacizumab + GNS561
|
Atezolizumab
Bevacizumab
GNS561
|
0 |
1 |
Atezolizumab + Bevacizumab + Infigratinib
|
Atezolizumab
Bevacizumab
Infigratinib
|
0 |
1 |
Atezolizumab + Bevacizumab + Ipilimumab
|
Atezolizumab
Bevacizumab
Ipilimumab
|
0 |
1 |
Atezolizumab + Bevacizumab + NP137
|
Atezolizumab
Bevacizumab
NP137
|
0 |
1 |
Atezolizumab + Bevacizumab + Obinutuzumab + RO6874281
|
Atezolizumab
Bevacizumab
Obinutuzumab
RO6874281
|
0 |
1 |
Atezolizumab + Bevacizumab + Paclitaxel
|
Atezolizumab
Bevacizumab
Paclitaxel
|
0 |
3 |
Atezolizumab + Bevacizumab + PCV13 vaccine
|
Atezolizumab
Bevacizumab
PCV13 vaccine
|
0 |
1 |
Atezolizumab + Bevacizumab + Peg-interferon alfa-2a
|
Atezolizumab
Bevacizumab
Peg-interferon alfa-2a
|
0 |
1 |
Atezolizumab + Bevacizumab + Pegylated liposomal doxorubicin
|
Atezolizumab
Bevacizumab
Pegylated liposomal doxorubicin
|
0 |
2 |
Atezolizumab + Bevacizumab + Pemetrexed Disodium
|
Atezolizumab
Bevacizumab
Pemetrexed Disodium
|
0 |
2 |
Atezolizumab + Bevacizumab + Pemigatinib
|
Atezolizumab
Bevacizumab
Pemigatinib
|
0 |
1 |
Atezolizumab + Bevacizumab + PGG beta-glucan
|
Atezolizumab
Bevacizumab
PGG beta-glucan
|
0 |
1 |
Atezolizumab + Bevacizumab + PXS-5505
|
Atezolizumab
Bevacizumab
PXS-5505
|
0 |
1 |
Atezolizumab + Bevacizumab + RP2
|
Atezolizumab
Bevacizumab
RP2
|
0 |
1 |
Atezolizumab + Bevacizumab + RP3
|
Atezolizumab
Bevacizumab
RP3
|
0 |
2 |
Atezolizumab + Bevacizumab + Rucaparib
|
Atezolizumab
Bevacizumab
Rucaparib
|
0 |
1 |
Atezolizumab + Bevacizumab + SAR439459
|
Atezolizumab
Bevacizumab
SAR439459
|
0 |
0 |
Atezolizumab + Bevacizumab + Selicrelumab
|
Atezolizumab
Bevacizumab
Selicrelumab
|
0 |
1 |
Atezolizumab + Bevacizumab + Selinexor
|
Atezolizumab
Bevacizumab
Selinexor
|
0 |
1 |
Atezolizumab + Bevacizumab + SRF388
|
Atezolizumab
Bevacizumab
SRF388
|
0 |
1 |
Atezolizumab + Bevacizumab + Tamoxifen
|
Atezolizumab
Bevacizumab
Tamoxifen
|
0 |
1 |
Atezolizumab + Bevacizumab + Tiragolumab
|
Atezolizumab
Bevacizumab
Tiragolumab
|
0 |
4 |
Atezolizumab + Bevacizumab + Tocilizumab
|
Atezolizumab
Bevacizumab
Tocilizumab
|
0 |
1 |
Atezolizumab + Bevacizumab + TPST-1120
|
Atezolizumab
Bevacizumab
TPST-1120
|
0 |
0 |
Atezolizumab + Bevacizumab + Tretinoin
|
Atezolizumab
Bevacizumab
Tretinoin
|
0 |
1 |
Atezolizumab + Bevacizumab + UCPVax
|
Atezolizumab
Bevacizumab
UCPVax
|
0 |
1 |
Atezolizumab + Bevacizumab + Vancomycin
|
Atezolizumab
Bevacizumab
Vancomycin
|
0 |
0 |
Avelumab + Bevacizumab + Epacadostat
|
Avelumab
Bevacizumab
Epacadostat
|
0 |
0 |
Avelumab + Bevacizumab + ETBX-011 + GI-4000 + Nogapendekin alfa inbakicept
|
Avelumab
Bevacizumab
ETBX-011
GI-4000
Nogapendekin alfa inbakicept
|
0 |
1 |
Axitinib + Bevacizumab
|
Axitinib
Bevacizumab
|
0 |
0 |
Balstilimab + Bevacizumab + Botensilimab + Fluorouracil + Leucovorin + Oxaliplatin
|
Balstilimab
Bevacizumab
Botensilimab
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
2 |
Bevacizumab
|
Bevacizumab
|
2 |
134 |
Bevacizumab + BI 905711 + Fluorouracil + Irinotecan + Leucovorin
|
BI 905711
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
|
0 |
1 |
Bevacizumab + Binimetinib + Pembrolizumab
|
Bevacizumab
Binimetinib
Pembrolizumab
|
0 |
1 |
Bevacizumab + Bintrafusp alfa + Carboplatin + Paclitaxel
|
Bevacizumab
Bintrafusp alfa
Carboplatin
Paclitaxel
|
0 |
1 |
Bevacizumab + Bintrafusp alfa + Cisplatin + Paclitaxel
|
Bevacizumab
Bintrafusp alfa
Cisplatin
Paclitaxel
|
0 |
1 |
Bevacizumab + Bortezomib
|
Bevacizumab
Bortezomib
|
0 |
1 |
Bevacizumab + Bortezomib + Temozolomide
|
Bevacizumab
Bortezomib
Temozolomide
|
0 |
1 |
Bevacizumab + Brentuximab vedotin
|
Bevacizumab
Brentuximab vedotin
|
0 |
1 |
Bevacizumab + Brigatinib
|
Bevacizumab
Brigatinib
|
0 |
1 |
Bevacizumab + Brigatinib + Osimertinib
|
Bevacizumab
Brigatinib
Osimertinib
|
0 |
0 |
Bevacizumab + Buparlisib
|
Bevacizumab
Buparlisib
|
0 |
2 |
Bevacizumab + Cadonilimab
|
Bevacizumab
Cadonilimab
|
0 |
0 |
Bevacizumab + Cadonilimab + Carboplatin + Paclitaxel
|
Bevacizumab
Cadonilimab
Carboplatin
Paclitaxel
|
0 |
0 |
Bevacizumab + Cadonilimab + Cisplatin + Paclitaxel
|
Bevacizumab
Cadonilimab
Cisplatin
Paclitaxel
|
0 |
0 |
Bevacizumab + Cannabidiol + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin
|
Bevacizumab
Cannabidiol
Fluorouracil
Irinotecan
Leucovorin
Oxaliplatin
|
0 |
1 |
Bevacizumab + Capecitabine
|
Bevacizumab
Capecitabine
|
0 |
10 |
Bevacizumab + Capecitabine + Carboplatin
|
Bevacizumab
Capecitabine
Carboplatin
|
0 |
1 |
Bevacizumab + Capecitabine + CV301 + Durvalumab
|
Bevacizumab
CV301
Capecitabine
Durvalumab
|
0 |
1 |
Bevacizumab + Capecitabine + Datopotamab deruxtecan
|
Bevacizumab
Capecitabine
Datopotamab deruxtecan
|
0 |
1 |
Bevacizumab + Capecitabine + Fluorouracil + Irinotecan + Leucovorin
|
Bevacizumab
Capecitabine
Fluorouracil
Irinotecan
Leucovorin
|
0 |
0 |
Bevacizumab + Capecitabine + Fluorouracil + Leucovorin
|
Bevacizumab
Capecitabine
Fluorouracil
Leucovorin
|
0 |
1 |
Bevacizumab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin
|
Bevacizumab
Capecitabine
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
1 |
Bevacizumab + Capecitabine + Irinotecan
|
Bevacizumab
Capecitabine
Irinotecan
|
0 |
1 |
Bevacizumab + Capecitabine + LBL-007
|
Bevacizumab
Capecitabine
LBL-007
|
0 |
1 |
Bevacizumab + Capecitabine + LBL-007 + Tislelizumab
|
Bevacizumab
Capecitabine
LBL-007
Tislelizumab
|
0 |
1 |
Bevacizumab + Capecitabine + Oxaliplatin
|
Bevacizumab
Capecitabine
Oxaliplatin
|
0 |
8 |
Bevacizumab + Capecitabine + Oxaliplatin + Pembrolizumab
|
Bevacizumab
Capecitabine
Oxaliplatin
Pembrolizumab
|
0 |
1 |
Bevacizumab + Capecitabine + Oxaliplatin + Toripalimab-tpzi
|
Bevacizumab
Capecitabine
Oxaliplatin
Toripalimab-tpzi
|
0 |
0 |
Bevacizumab + Capecitabine + Oxaliplatin + Trastuzumab
|
Bevacizumab
Capecitabine
Oxaliplatin
Trastuzumab
|
0 |
0 |
Bevacizumab + Capecitabine + Oxaliplatin + Valproic acid
|
Bevacizumab
Capecitabine
Oxaliplatin
Valproic acid
|
0 |
1 |
Bevacizumab + Capecitabine + Paclitaxel
|
Bevacizumab
Capecitabine
Paclitaxel
|
0 |
0 |
Bevacizumab + Capecitabine + Pembrolizumab
|
Bevacizumab
Capecitabine
Pembrolizumab
|
0 |
1 |
Bevacizumab + Capecitabine + Temozolomide
|
Bevacizumab
Capecitabine
Temozolomide
|
0 |
2 |
Bevacizumab + Capecitabine + Trifluridine-tipiracil hydrochloride
|
Bevacizumab
Capecitabine
Trifluridine-tipiracil hydrochloride
|
0 |
1 |
Bevacizumab + Capecitabine + Valproic acid
|
Bevacizumab
Capecitabine
Valproic acid
|
0 |
1 |
Bevacizumab + Capecitabine + Vemurafenib
|
Bevacizumab
Capecitabine
Vemurafenib
|
1 |
0 |
Bevacizumab + Capmatinib
|
Bevacizumab
Capmatinib
|
0 |
1 |
Bevacizumab + Carboplatin
|
Bevacizumab
Carboplatin
|
0 |
4 |
Bevacizumab + Carboplatin + Cixutumumab + Paclitaxel
|
Bevacizumab
Carboplatin
Cixutumumab
Paclitaxel
|
0 |
0 |
Bevacizumab + Carboplatin + DNIB0600A
|
Bevacizumab
Carboplatin
DNIB0600A
|
0 |
1 |
Bevacizumab + Carboplatin + Docetaxel
|
Bevacizumab
Carboplatin
Docetaxel
|
0 |
1 |
Bevacizumab + Carboplatin + Durvalumab + Paclitaxel
|
Bevacizumab
Carboplatin
Durvalumab
Paclitaxel
|
0 |
1 |
Bevacizumab + Carboplatin + Ensartinib + Pemetrexed Disodium
|
Bevacizumab
Carboplatin
Ensartinib
Pemetrexed Disodium
|
0 |
1 |
Bevacizumab + Carboplatin + Everolimus + Paclitaxel
|
Bevacizumab
Carboplatin
Everolimus
Paclitaxel
|
0 |
1 |
Bevacizumab + Carboplatin + Gefitinib + Pemetrexed Disodium
|
Bevacizumab
Carboplatin
Gefitinib
Pemetrexed Disodium
|
0 |
0 |
Bevacizumab + Carboplatin + Gemcitabine
|
Bevacizumab
Carboplatin
Gemcitabine
|
0 |
2 |
Bevacizumab + Carboplatin + Gemcitabine + Paclitaxel
|
Bevacizumab
Carboplatin
Gemcitabine
Paclitaxel
|
0 |
0 |
Bevacizumab + Carboplatin + Gemcitabine + Paclitaxel + Pegylated liposomal doxorubicin
|
Bevacizumab
Carboplatin
Gemcitabine
Paclitaxel
Pegylated liposomal doxorubicin
|
0 |
1 |
Bevacizumab + Carboplatin + GEN-1 + Paclitaxel
|
Bevacizumab
Carboplatin
GEN-1
Paclitaxel
|
0 |
1 |
Bevacizumab + Carboplatin + GL-ONC1
|
Bevacizumab
Carboplatin
GL-ONC1
|
0 |
1 |
Bevacizumab + Carboplatin + Hydroxychloroquine + Paclitaxel
|
Bevacizumab
Carboplatin
Hydroxychloroquine
Paclitaxel
|
0 |
1 |
Bevacizumab + Carboplatin + MK-4830 + Paclitaxel + Pembrolizumab
|
Bevacizumab
Carboplatin
MK-4830
Paclitaxel
Pembrolizumab
|
0 |
1 |
Bevacizumab + Carboplatin + Nab-paclitaxel
|
Bevacizumab
Carboplatin
Nab-paclitaxel
|
0 |
2 |
Bevacizumab + Carboplatin + Olaparib + Paclitaxel + Pembrolizumab
|
Bevacizumab
Carboplatin
Olaparib
Paclitaxel
Pembrolizumab
|
0 |
1 |
Bevacizumab + Carboplatin + Olaparib + Pembrolizumab
|
Bevacizumab
Carboplatin
Olaparib
Pembrolizumab
|
0 |
0 |
Bevacizumab + Carboplatin + Paclitaxel
|
Bevacizumab
Carboplatin
Paclitaxel
|
0 |
15 |
Bevacizumab + Carboplatin + Paclitaxel + Pembrolizumab
|
Bevacizumab
Carboplatin
Paclitaxel
Pembrolizumab
|
0 |
4 |
Bevacizumab + Carboplatin + Paclitaxel + Rucaparib
|
Bevacizumab
Carboplatin
Paclitaxel
Rucaparib
|
0 |
1 |
Bevacizumab + Carboplatin + Pembrolizumab
|
Bevacizumab
Carboplatin
Pembrolizumab
|
0 |
0 |
Bevacizumab + Carboplatin + Pemetrexed Disodium
|
Bevacizumab
Carboplatin
Pemetrexed Disodium
|
0 |
3 |
Bevacizumab + Carboplatin + Pemetrexed Disodium + PSB205
|
Bevacizumab
Carboplatin
PSB205
Pemetrexed Disodium
|
0 |
0 |
Bevacizumab + Carboxyamidotriazole Orotate
|
Bevacizumab
Carboxyamidotriazole Orotate
|
0 |
0 |
Bevacizumab + Carmustine
|
Bevacizumab
Carmustine
|
0 |
1 |
Bevacizumab + Carotuximab
|
Bevacizumab
Carotuximab
|
0 |
4 |
Bevacizumab + CBP-1019 + Fluorouracil + Leucovorin + Oxaliplatin
|
Bevacizumab
CBP-1019
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
1 |
Bevacizumab + CDX-1140 + Pembrolizumab
|
Bevacizumab
CDX-1140
Pembrolizumab
|
0 |
1 |
Bevacizumab + Cediranib
|
Bevacizumab
Cediranib
|
0 |
0 |
Bevacizumab + Cetuximab
|
Bevacizumab
Cetuximab
|
0 |
2 |
Bevacizumab + Cetuximab + CIMAvax-EGF + Leucovorin
|
Bevacizumab
CIMAvax-EGF
Cetuximab
Leucovorin
|
0 |
1 |
Bevacizumab + Cetuximab + Encorafenib
|
Bevacizumab
Cetuximab
Encorafenib
|
0 |
1 |
Bevacizumab + Cetuximab + Erlotinib
|
Bevacizumab
Cetuximab
Erlotinib
|
0 |
0 |
Bevacizumab + Cetuximab + Fluorouracil + Irinotecan + Leucovorin
|
Bevacizumab
Cetuximab
Fluorouracil
Irinotecan
Leucovorin
|
0 |
0 |
Bevacizumab + Cetuximab + Irinotecan
|
Bevacizumab
Cetuximab
Irinotecan
|
0 |
1 |
Bevacizumab + Cetuximab + Temsirolimus
|
Bevacizumab
Cetuximab
Temsirolimus
|
0 |
1 |
Bevacizumab + Cetuximab + Temsirolimus + Valproic acid
|
Bevacizumab
Cetuximab
Temsirolimus
Valproic acid
|
0 |
0 |
Bevacizumab + Chidamide + Sintilimab
|
Bevacizumab
Chidamide
Sintilimab
|
0 |
0 |
Bevacizumab + Cholecalciferol + Fluorouracil + Irinotecan + Leucovorin
|
Bevacizumab
Cholecalciferol
Fluorouracil
Irinotecan
Leucovorin
|
0 |
1 |
Bevacizumab + Cholecalciferol + Fluorouracil + Leucovorin + Oxaliplatin
|
Bevacizumab
Cholecalciferol
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
1 |
Bevacizumab + CIMAvax-EGF + Fluorouracil + Leucovorin + Oxaliplatin
|
Bevacizumab
CIMAvax-EGF
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
1 |
Bevacizumab + Cisplatin
|
Bevacizumab
Cisplatin
|
0 |
1 |
Bevacizumab + Cisplatin + Docetaxel
|
Bevacizumab
Cisplatin
Docetaxel
|
0 |
1 |
Bevacizumab + Cisplatin + Etoposide
|
Bevacizumab
Cisplatin
Etoposide
|
0 |
0 |
Bevacizumab + Cisplatin + Gemcitabine
|
Bevacizumab
Cisplatin
Gemcitabine
|
0 |
2 |
Bevacizumab + Cisplatin + GL-ONC1
|
Bevacizumab
Cisplatin
GL-ONC1
|
0 |
1 |
Bevacizumab + Cisplatin + Olaparib + Paclitaxel
|
Bevacizumab
Cisplatin
Olaparib
Paclitaxel
|
0 |
1 |
Bevacizumab + Cisplatin + Paclitaxel
|
Bevacizumab
Cisplatin
Paclitaxel
|
0 |
3 |
Bevacizumab + Cisplatin + Paclitaxel + Pembrolizumab
|
Bevacizumab
Cisplatin
Paclitaxel
Pembrolizumab
|
0 |
2 |
Bevacizumab + Cisplatin + Paclitaxel + Prolgolimab
|
Bevacizumab
Cisplatin
Paclitaxel
Prolgolimab
|
0 |
1 |
Bevacizumab + Cisplatin + Pembrolizumab
|
Bevacizumab
Cisplatin
Pembrolizumab
|
0 |
0 |
Bevacizumab + Crizotinib
|
Bevacizumab
Crizotinib
|
0 |
0 |
Bevacizumab + Crizotinib + Gefitinib
|
Bevacizumab
Crizotinib
Gefitinib
|
0 |
0 |
Bevacizumab + Crizotinib + Osimertinib
|
Bevacizumab
Crizotinib
Osimertinib
|
0 |
0 |
Bevacizumab + CVX-060
|
Bevacizumab
CVX-060
|
0 |
0 |
Bevacizumab + Cyclophosphamide + Docetaxel + Epirubicin + Fluorouracil
|
Bevacizumab
Cyclophosphamide
Docetaxel
Epirubicin
Fluorouracil
|
0 |
0 |
Bevacizumab + Cyclophosphamide + Doxorubicin + Etoposide + Ifosfamide + Irinotecan + Sorafenib + Temozolomide + Temsirolimus + Vincristine Sulfate
|
Bevacizumab
Cyclophosphamide
Doxorubicin
Etoposide
Ifosfamide
Irinotecan
Sorafenib
Temozolomide
Temsirolimus
Vincristine Sulfate
|
0 |
1 |
Bevacizumab + Cyclophosphamide + Doxorubicin + Paclitaxel
|
Bevacizumab
Cyclophosphamide
Doxorubicin
Paclitaxel
|
0 |
1 |
Bevacizumab + Cyclophosphamide + LVGN3616 + LVGN6051
|
Bevacizumab
Cyclophosphamide
LVGN3616
LVGN6051
|
0 |
1 |
Bevacizumab + Cyclophosphamide + LVGN3616 + LVGN6051 + LVGN7409
|
Bevacizumab
Cyclophosphamide
LVGN3616
LVGN6051
LVGN7409
|
0 |
1 |
Bevacizumab + Cyclophosphamide + Pembrolizumab
|
Bevacizumab
Cyclophosphamide
Pembrolizumab
|
0 |
2 |
Bevacizumab + Cyclophosphamide + Sorafenib
|
Bevacizumab
Cyclophosphamide
Sorafenib
|
0 |
2 |
Bevacizumab + Cyclophosphamide + Topotecan
|
Bevacizumab
Cyclophosphamide
Topotecan
|
0 |
1 |
Bevacizumab + Cyclophosphamide + Zoledronic acid
|
Bevacizumab
Cyclophosphamide
Zoledronic acid
|
0 |
1 |
Bevacizumab + Dasatinib + Fluorouracil + Leucovorin + Oxaliplatin
|
Bevacizumab
Dasatinib
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
1 |
Bevacizumab + Datopotamab deruxtecan + Fluorouracil + Leucovorin
|
Bevacizumab
Datopotamab deruxtecan
Fluorouracil
Leucovorin
|
0 |
1 |
Bevacizumab + Dexamethasone + Evofosfamide
|
Bevacizumab
Dexamethasone
Evofosfamide
|
0 |
0 |
Bevacizumab + Divarasib
|
Bevacizumab
Divarasib
|
0 |
1 |
Bevacizumab + Docetaxel
|
Bevacizumab
Docetaxel
|
0 |
1 |
Bevacizumab + Docetaxel + Doxorubicin
|
Bevacizumab
Docetaxel
Doxorubicin
|
1 |
0 |
Bevacizumab + Docetaxel + Gemcitabine + Valproic acid
|
Bevacizumab
Docetaxel
Gemcitabine
Valproic acid
|
0 |
1 |
Bevacizumab + Docetaxel + MK-4830 + Paclitaxel + Pembrolizumab
|
Bevacizumab
Docetaxel
MK-4830
Paclitaxel
Pembrolizumab
|
0 |
1 |
Bevacizumab + Docetaxel + Paclitaxel + Pembrolizumab
|
Bevacizumab
Docetaxel
Paclitaxel
Pembrolizumab
|
0 |
1 |
Bevacizumab + Docetaxel + Pembrolizumab
|
Bevacizumab
Docetaxel
Pembrolizumab
|
0 |
1 |
Bevacizumab + Dostarlimab-gxly + Niraparib
|
Bevacizumab
Dostarlimab-gxly
Niraparib
|
0 |
2 |
Bevacizumab + Dostarlimab-gxly + Paclitaxel
|
Bevacizumab
Dostarlimab-gxly
Paclitaxel
|
0 |
1 |
Bevacizumab + Doxorubicin
|
Bevacizumab
Doxorubicin
|
0 |
1 |
Bevacizumab + Doxorubicin + Durvalumab
|
Bevacizumab
Doxorubicin
Durvalumab
|
0 |
1 |
Bevacizumab + Doxorubicin + Everolimus
|
Bevacizumab
Doxorubicin
Everolimus
|
1 |
0 |
Bevacizumab + Doxorubicin + Temsirolimus
|
Bevacizumab
Doxorubicin
Temsirolimus
|
1 |
1 |
Bevacizumab + DSP-7888
|
Bevacizumab
DSP-7888
|
0 |
1 |
Bevacizumab + Durvalumab
|
Bevacizumab
Durvalumab
|
0 |
5 |
Bevacizumab + Durvalumab + Fluorouracil + Leucovorin + Oxaliplatin + Tremelimumab
|
Bevacizumab
Durvalumab
Fluorouracil
Leucovorin
Oxaliplatin
Tremelimumab
|
0 |
1 |
Bevacizumab + Durvalumab + Olaparib
|
Bevacizumab
Durvalumab
Olaparib
|
0 |
2 |
Bevacizumab + Durvalumab + Tremelimumab
|
Bevacizumab
Durvalumab
Tremelimumab
|
0 |
1 |
Bevacizumab + Emactuzumab + Paclitaxel
|
Bevacizumab
Emactuzumab
Paclitaxel
|
0 |
1 |
Bevacizumab + EO2401 + Nivolumab
|
Bevacizumab
EO2401
Nivolumab
|
0 |
0 |
Bevacizumab + Epacadostat + Radiotherapy + Retifanlimab
|
Bevacizumab
Epacadostat
Radiotherapy
Retifanlimab
|
0 |
1 |
Bevacizumab + Erlotinib
|
Bevacizumab
Erlotinib
|
0 |
5 |
Bevacizumab + Erlotinib + Gemcitabine
|
Bevacizumab
Erlotinib
Gemcitabine
|
0 |
0 |
Bevacizumab + Erlotinib + Nab-paclitaxel
|
Bevacizumab
Erlotinib
Nab-paclitaxel
|
0 |
1 |
Bevacizumab + Erlotinib + Temozolomide
|
Bevacizumab
Erlotinib
Temozolomide
|
0 |
1 |
Bevacizumab + Etrumadenant + Fluorouracil + Leucovorin + Oxaliplatin + Zimberelimab
|
Bevacizumab
Etrumadenant
Fluorouracil
Leucovorin
Oxaliplatin
Zimberelimab
|
0 |
1 |
Bevacizumab + Everolimus
|
Bevacizumab
Everolimus
|
1 |
4 |
Bevacizumab + Evofosfamide
|
Bevacizumab
Evofosfamide
|
0 |
2 |
Bevacizumab + FANG vaccine
|
Bevacizumab
FANG vaccine
|
0 |
1 |
Bevacizumab + Fluorouracil
|
Bevacizumab
Fluorouracil
|
0 |
3 |
Bevacizumab + Fluorouracil + HRS-1167 + Irinotecan + Leucovorin
|
Bevacizumab
Fluorouracil
HRS-1167
Irinotecan
Leucovorin
|
0 |
1 |
Bevacizumab + Fluorouracil + Hu5F9-G4 + Irinotecan + Leucovorin
|
Bevacizumab
Fluorouracil
Hu5F9-G4
Irinotecan
Leucovorin
|
0 |
1 |
Bevacizumab + Fluorouracil + Hydroxychloroquine + Irinotecan + Leucovorin
|
Bevacizumab
Fluorouracil
Hydroxychloroquine
Irinotecan
Leucovorin
|
0 |
1 |
Bevacizumab + Fluorouracil + IGM-8444 + Irinotecan + Leucovorin
|
Bevacizumab
Fluorouracil
IGM-8444
Irinotecan
Leucovorin
|
0 |
1 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
|
0 |
20 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Napabucasin
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
Napabucasin
|
0 |
0 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + NEO212
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
NEO212
|
0 |
1 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + NIS793
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
NIS793
|
0 |
1 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Nivolumab + Oxaliplatin
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Onvansertib
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
Onvansertib
|
0 |
3 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
Oxaliplatin
|
0 |
10 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + RMC-6236
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
Oxaliplatin
RMC-6236
|
0 |
1 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Pelareorep
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
Pelareorep
|
0 |
0 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + RGX202
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
RGX202
|
0 |
1 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Temozolomide
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
Temozolomide
|
0 |
1 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + XOMA 052
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
XOMA 052
|
0 |
1 |
Bevacizumab + Fluorouracil + Irinotecan + Oxaliplatin
|
Bevacizumab
Fluorouracil
Irinotecan
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + LBL-007
|
Bevacizumab
Fluorouracil
LBL-007
|
0 |
1 |
Bevacizumab + Fluorouracil + LBL-007 + Tislelizumab
|
Bevacizumab
Fluorouracil
LBL-007
Tislelizumab
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin
|
Bevacizumab
Fluorouracil
Leucovorin
|
0 |
4 |
Bevacizumab + Fluorouracil + Leucovorin + Nab-paclitaxel + Oxaliplatin
|
Bevacizumab
Fluorouracil
Leucovorin
Nab-paclitaxel
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Nab-rapamycin + Oxaliplatin
|
Bevacizumab
Fluorouracil
Leucovorin
Nab-rapamycin
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + NANT-008 + Oxaliplatin
|
Bevacizumab
Fluorouracil
Leucovorin
NANT-008
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + NIS793 + Oxaliplatin
|
Bevacizumab
Fluorouracil
Leucovorin
NIS793
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
Bevacizumab
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
|
0 |
29 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + Panitumumab
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
Panitumumab
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + PF-07934040
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
PF-07934040
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + RGX202
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
RGX202
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + Riluzole
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
Riluzole
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + RMC-6236
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
RMC-6236
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + Valproic acid
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
Valproic acid
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + XOMA 052
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
XOMA 052
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + ZW25
|
Bevacizumab
Fluorouracil
Leucovorin
Oxaliplatin
ZW25
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Streptozocin
|
Bevacizumab
Fluorouracil
Leucovorin
Streptozocin
|
0 |
1 |
Bevacizumab + Fluorouracil + Oxaliplatin
|
Bevacizumab
Fluorouracil
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + Valproic acid
|
Bevacizumab
Fluorouracil
Valproic acid
|
0 |
1 |
Bevacizumab + Fosbretabulin
|
Bevacizumab
Fosbretabulin
|
0 |
1 |
Bevacizumab + Gefitinib
|
Bevacizumab
Gefitinib
|
0 |
0 |
Bevacizumab + Gefitinib + Nedaplatin + Paclitaxel
|
Bevacizumab
Gefitinib
Nedaplatin
Paclitaxel
|
0 |
0 |
Bevacizumab + Gemcitabine
|
Bevacizumab
Gemcitabine
|
0 |
3 |
Bevacizumab + Gemcitabine + Nab-paclitaxel
|
Bevacizumab
Gemcitabine
Nab-paclitaxel
|
0 |
1 |
Bevacizumab + Gemcitabine + Oxaliplatin
|
Bevacizumab
Gemcitabine
Oxaliplatin
|
0 |
2 |
Bevacizumab + IACS-6274 + Paclitaxel
|
Bevacizumab
IACS-6274
Paclitaxel
|
0 |
1 |
Bevacizumab + Icotinib
|
Bevacizumab
Icotinib
|
0 |
0 |
Bevacizumab + Inavolisib
|
Bevacizumab
Inavolisib
|
0 |
1 |
Bevacizumab + Ipilimumab
|
Bevacizumab
Ipilimumab
|
0 |
1 |
Bevacizumab + Irinotecan
|
Bevacizumab
Irinotecan
|
0 |
1 |
Bevacizumab + Irinotecan + Mebendazole
|
Bevacizumab
Irinotecan
Mebendazole
|
0 |
1 |
Bevacizumab + Irinotecan + Omburtamab I-131 + Temozolomide
|
Bevacizumab
Irinotecan
Omburtamab I-131
Temozolomide
|
0 |
1 |
Bevacizumab + Irinotecan + Oxaliplatin + Trifluridine-tipiracil hydrochloride
|
Bevacizumab
Irinotecan
Oxaliplatin
Trifluridine-tipiracil hydrochloride
|
0 |
1 |
Bevacizumab + Irinotecan + SGT-53 + Temozolomide
|
Bevacizumab
Irinotecan
SGT-53
Temozolomide
|
0 |
1 |
Bevacizumab + Irinotecan + Temozolomide
|
Bevacizumab
Irinotecan
Temozolomide
|
0 |
4 |
Bevacizumab + Irinotecan + Trifluridine-tipiracil hydrochloride
|
Bevacizumab
Irinotecan
Trifluridine-tipiracil hydrochloride
|
0 |
1 |
Bevacizumab + Ixabepilone
|
Bevacizumab
Ixabepilone
|
0 |
2 |
Bevacizumab + Liposomal irinotecan
|
Bevacizumab
Liposomal irinotecan
|
0 |
1 |
Bevacizumab + Liposomal irinotecan + Trifluridine-tipiracil hydrochloride
|
Bevacizumab
Liposomal irinotecan
Trifluridine-tipiracil hydrochloride
|
0 |
1 |
Bevacizumab + Lomustine
|
Bevacizumab
Lomustine
|
1 |
2 |
Bevacizumab + Lorlatinib
|
Bevacizumab
Lorlatinib
|
3 |
0 |
Bevacizumab + Lurbinectedin + Paclitaxel
|
Bevacizumab
Lurbinectedin
Paclitaxel
|
0 |
2 |
Bevacizumab + Luveltamab Tazevibulin
|
Bevacizumab
Luveltamab Tazevibulin
|
0 |
1 |
Bevacizumab + Marizomib
|
Bevacizumab
Marizomib
|
0 |
1 |
Bevacizumab + ME-344
|
Bevacizumab
ME-344
|
0 |
1 |
Bevacizumab + MEDI3617
|
Bevacizumab
MEDI3617
|
0 |
0 |
Bevacizumab + MEDI5752
|
Bevacizumab
MEDI5752
|
0 |
1 |
Bevacizumab + MINT1526A
|
Bevacizumab
MINT1526A
|
0 |
0 |
Bevacizumab + Mirvetuximab Soravtansine
|
Bevacizumab
Mirvetuximab Soravtansine
|
0 |
2 |
Bevacizumab + Mobocertinib
|
Bevacizumab
Mobocertinib
|
0 |
0 |
Bevacizumab + Nab-paclitaxel
|
Bevacizumab
Nab-paclitaxel
|
0 |
1 |
Bevacizumab + Nab-paclitaxel + Temozolomide
|
Bevacizumab
Nab-paclitaxel
Temozolomide
|
0 |
1 |
Bevacizumab + Nab-rapamycin
|
Bevacizumab
Nab-rapamycin
|
0 |
1 |
Bevacizumab + Napabucasin
|
Bevacizumab
Napabucasin
|
0 |
1 |
Bevacizumab + Nintedanib
|
Bevacizumab
Nintedanib
|
0 |
1 |
Bevacizumab + Niraparib
|
Bevacizumab
Niraparib
|
0 |
6 |
Bevacizumab + Nivolumab
|
Bevacizumab
Nivolumab
|
0 |
6 |
Bevacizumab + Nivolumab + Relatlimab
|
Bevacizumab
Nivolumab
Relatlimab
|
0 |
1 |
Bevacizumab + NLG207
|
Bevacizumab
NLG207
|
0 |
2 |
Bevacizumab + Nogapendekin alfa inbakicept + PD-L1.t-haNK cells
|
Bevacizumab
Nogapendekin alfa inbakicept
PD-L1.t-haNK cells
|
0 |
1 |
Bevacizumab + NOX-A12
|
Bevacizumab
NOX-A12
|
0 |
1 |
Bevacizumab + Olaparib
|
Bevacizumab
Olaparib
|
0 |
3 |
Bevacizumab + Olaparib + Paclitaxel + Pembrolizumab
|
Bevacizumab
Olaparib
Paclitaxel
Pembrolizumab
|
0 |
0 |
Bevacizumab + Olaparib + Pembrolizumab
|
Bevacizumab
Olaparib
Pembrolizumab
|
0 |
0 |
Bevacizumab + ONC201
|
Bevacizumab
ONC201
|
0 |
0 |
Bevacizumab + Osimertinib
|
Bevacizumab
Osimertinib
|
0 |
3 |
Bevacizumab + OT-A201
|
Bevacizumab
OT-A201
|
0 |
1 |
Bevacizumab + Oxaliplatin + Sorafenib
|
Bevacizumab
Oxaliplatin
Sorafenib
|
0 |
1 |
Bevacizumab + Paclitaxel
|
Bevacizumab
Paclitaxel
|
0 |
8 |
Bevacizumab + Paclitaxel + Pembrolizumab
|
Bevacizumab
Paclitaxel
Pembrolizumab
|
0 |
1 |
Bevacizumab + Paclitaxel + Topotecan
|
Bevacizumab
Paclitaxel
Topotecan
|
0 |
0 |
Bevacizumab + Palbociclib
|
Bevacizumab
Palbociclib
|
0 |
1 |
Bevacizumab + Pamiparib
|
Bevacizumab
Pamiparib
|
0 |
0 |
Bevacizumab + Pazopanib
|
Bevacizumab
Pazopanib
|
0 |
1 |
Bevacizumab + Pegcetacoplan + Pembrolizumab
|
Bevacizumab
Pegcetacoplan
Pembrolizumab
|
0 |
1 |
Bevacizumab + Pegylated liposomal doxorubicin
|
Bevacizumab
Pegylated liposomal doxorubicin
|
0 |
5 |
Bevacizumab + Pegylated liposomal doxorubicin + Temsirolimus
|
Bevacizumab
Pegylated liposomal doxorubicin
Temsirolimus
|
3 |
1 |
Bevacizumab + Pelareorep
|
Bevacizumab
Pelareorep
|
0 |
1 |
Bevacizumab + Pembrolizumab
|
Bevacizumab
Pembrolizumab
|
0 |
7 |
Bevacizumab + Pembrolizumab + ZN-c3
|
Bevacizumab
Pembrolizumab
ZN-c3
|
0 |
1 |
Bevacizumab + Pemetrexed Disodium
|
Bevacizumab
Pemetrexed Disodium
|
0 |
1 |
Bevacizumab + PF-07329640
|
Bevacizumab
PF-07329640
|
0 |
1 |
Bevacizumab + Plerixafor
|
Bevacizumab
Plerixafor
|
0 |
1 |
Bevacizumab + PRX177561
|
Bevacizumab
PRX177561
|
0 |
0 |
Bevacizumab + Pyrotinib
|
Bevacizumab
Pyrotinib
|
0 |
0 |
Bevacizumab + Radiotherapy + Retifanlimab
|
Bevacizumab
Radiotherapy
Retifanlimab
|
0 |
1 |
Bevacizumab + Retifanlimab
|
Bevacizumab
Retifanlimab
|
0 |
1 |
Bevacizumab + Rindopepimut
|
Bevacizumab
Rindopepimut
|
0 |
0 |
Bevacizumab + RO7247669
|
Bevacizumab
RO7247669
|
0 |
1 |
Bevacizumab + Rucaparib
|
Bevacizumab
Rucaparib
|
0 |
1 |
Bevacizumab + S-49076
|
Bevacizumab
S-49076
|
0 |
0 |
Bevacizumab + Sacituzumab govitecan-hziy
|
Bevacizumab
Sacituzumab govitecan-hziy
|
0 |
1 |
Bevacizumab + Sapanisertib
|
Bevacizumab
Sapanisertib
|
0 |
1 |
Bevacizumab + Selicrelumab
|
Bevacizumab
Selicrelumab
|
0 |
1 |
Bevacizumab + sEphB4-HSA
|
Bevacizumab
sEphB4-HSA
|
0 |
0 |
Bevacizumab + Sintilimab
|
Bevacizumab
Sintilimab
|
0 |
0 |
Bevacizumab + SL-701
|
Bevacizumab
SL-701
|
0 |
0 |
Bevacizumab + Sorafenib
|
Bevacizumab
Sorafenib
|
1 |
0 |
Bevacizumab + Sorafenib + Temsirolimus
|
Bevacizumab
Sorafenib
Temsirolimus
|
0 |
0 |
Bevacizumab + Sotorasib
|
Bevacizumab
Sotorasib
|
0 |
0 |
Bevacizumab + Telatinib
|
Bevacizumab
Telatinib
|
0 |
0 |
Bevacizumab + Telisotuzumab vedotin
|
Bevacizumab
Telisotuzumab vedotin
|
0 |
1 |
Bevacizumab + Temozolomide
|
Bevacizumab
Temozolomide
|
0 |
9 |
Bevacizumab + Temozolomide + Topotecan
|
Bevacizumab
Temozolomide
Topotecan
|
0 |
1 |
Bevacizumab + Temsirolimus
|
Bevacizumab
Temsirolimus
|
1 |
1 |
Bevacizumab + Temsirolimus + Valproic acid
|
Bevacizumab
Temsirolimus
Valproic acid
|
0 |
1 |
Bevacizumab + Tisotumab vedotin-tftv
|
Bevacizumab
Tisotumab vedotin-tftv
|
0 |
1 |
Bevacizumab + Tivantinib
|
Bevacizumab
Tivantinib
|
0 |
1 |
Bevacizumab + Topotecan
|
Bevacizumab
Topotecan
|
0 |
2 |
Bevacizumab + Toripalimab-tpzi
|
Bevacizumab
Toripalimab-tpzi
|
0 |
0 |
Bevacizumab + Trastuzumab
|
Bevacizumab
Trastuzumab
|
0 |
1 |
Bevacizumab + Trebananib
|
Bevacizumab
Trebananib
|
0 |
2 |
Bevacizumab + Trifluridine-tipiracil hydrochloride
|
Bevacizumab
Trifluridine-tipiracil hydrochloride
|
0 |
5 |
Bevacizumab + Trifluridine-tipiracil hydrochloride + XB2001
|
Bevacizumab
Trifluridine-tipiracil hydrochloride
XB2001
|
0 |
0 |
Bevacizumab + TVB-2640
|
Bevacizumab
TVB-2640
|
0 |
1 |
Bevacizumab + VB-111
|
Bevacizumab
VB-111
|
0 |
2 |
Bevacizumab + Veliparib
|
Bevacizumab
Veliparib
|
0 |
1 |
Bevacizumab + Vemurafenib
|
Bevacizumab
Vemurafenib
|
1 |
0 |
Bevacizumab + Vinblastine
|
Bevacizumab
Vinblastine
|
0 |
1 |
Bevacizumab + Vorinostat
|
Bevacizumab
Vorinostat
|
0 |
1 |
Bevacizumab + ZN-c3
|
Bevacizumab
ZN-c3
|
0 |
1 |